Paper3145014
Cost-benefit analysis of cephradine and mezlocillin prophylaxis for abdominal and vaginal hysterectomy.
Davey PG and 3 others. Br J Obstet Gynaecol, 1988. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Cost-benefit analysis of cephradine and mezlocillin prophylaxis for abdominal and vaginal hysterectomy. Papers, record 3145014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3145014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cephalosporins | Major topic |
| Cephradine | Major topic |
| Hysterectomy | Major topic |
| Mezlocillin | Major topic |
| Premedication | Major topic |
| Surgical Wound Infection | Major topic |
| Adult | |
| Clinical Trials as Topic | |
| Cost-Benefit Analysis | |
| Female | |
| Humans | |
| Random Allocation |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29951632 | Systematic review of the cost-effectiveness of preoperative antibiotic prophylaxis in reducing surgical-site infection. | BJS Open | 2018 | https://conductscience.org/library/papers/29951632 | PubMed |
| 28462657 | Second generation cephalosporin antibiotic prophylaxis and Clostridium difficile infection in hip and knee arthroplasty. | Ann R Coll Surg Engl | 2017 | https://conductscience.org/library/papers/28462657 | PubMed |
| 15599747 | Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery. | World J Surg | 2005 | https://conductscience.org/library/papers/15599747 | PubMed |
| 10172460 | The cost effectiveness of amoxicillin/clavulanic acid as antibacterial prophylaxis in abdominal and gynaecological surgery. | Pharmacoeconomics | 1995 | https://conductscience.org/library/papers/10172460 | PubMed |
| 10163416 | Cost-effective prophylaxis of surgical infections. | Pharmacoeconomics | 1996 | https://conductscience.org/library/papers/10163416 | PubMed |
| 10147022 | Pharmacoeconomics of antibacterial treatment. | Pharmacoeconomics | 1992 | https://conductscience.org/library/papers/10147022 | PubMed |
| 10147017 | Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions. | Pharmacoeconomics | 1992 | https://conductscience.org/library/papers/10147017 | PubMed |
| 2511938 | Reducing the incidence of infection after caesarean section: implications of prophylaxis with antibiotics for hospital resources. | BMJ | 1989 | https://conductscience.org/library/papers/2511938 | PubMed |
| 2508906 | The role of health economics. | BMJ | 1989 | https://conductscience.org/library/papers/2508906 | PubMed |
| 1706985 | Antibiotic prophylaxis in hysterectomy and induced abortion. A review of the evidence. | Drugs | 1991 | https://conductscience.org/library/papers/1706985 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3145014
GET https://conductscience.org/api/papers/v1/3145014/authors